Euro area vs Sweden: Access to anti-retroviral drugs, male
Euro area
87.0%
in 2022
Sweden
95.0%
in 2022
Euro area rank
1st
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- Euro area
- Sweden
How they compare
Sweden currently reports 95.0% against 87.0% in Euro area, a difference of 8.0%.
That makes Sweden's figure about 1.1 times Euro area's.
The two have swapped places 3 times across 23 shared years of data; in 2000 it was Euro area ahead.
Euro area ranks 1st and Sweden ranks 4th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Euro area | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.7% | 53.7% | 3.0% | Sweden |
| 2010s | 75.2% | 92.5% | 17.3% | Sweden |
| 2020s | 86.1% | 95.3% | 9.3% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Euro area or Sweden?
- Sweden, at 95.0% against 87.0% in Euro area as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Euro area and Sweden?
- 8.0%, with Sweden ahead.
- How many years of comparable data are there for Euro area and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Euro area and Sweden rank globally for access to anti-retroviral drugs, male?
- Euro area ranks 1st and Sweden ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.